Indication
Anticholinergic toxicity
Anticholinergic toxicity is an acute toxic syndrome caused by the competitive antagonism of acetylcholine at central and peripheral muscarinic receptors. Read more about Anticholinergic toxicity
2 drugs 2 manufacturers
Drugs that treat it
Common Anticholinergic toxicity therapies.
ANTICHOLIUM (physostigmine salicylate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAnticholinergic toxicity is an acute toxic syndrome caused by the competitive antagonism of acetylcholine at central and peripheral muscarinic receptors.
It typically affects the central nervous system and the autonomic nervous system across diverse patient populations, with older adults exhibiting heightened vulnerability due to age-related pharmacokinetic changes and polypharmacy.
Clinically, the toxidrome is defined by peripheral signs of parasympathetic blockade—including tachycardia, mydriasis, anhidrosis, hyperthermia, dry mucous membranes, urinary retention, and decreased bowel sounds—accompanied by central manifestations such as confusion, agitation, visual hallucinations, delirium, and potentially seizures or coma.
- nih.gov
Anticholinergic toxicity is an acute toxic syndrome caused by the competitive antagonism of acetylcholine at central and peripheral muscarinic receptors
- nih.gov
Anticholinergic toxicity is an acute toxic syndrome caused by the competitive antagonism of acetylcholine at central and peripheral muscarinic receptors
- nih.gov
Anticholinergic toxicity is an acute toxic syndrome caused by the competitive antagonism of acetylcholine at central and peripheral muscarinic receptors
- nih.gov
It typically affects the central nervous system and the autonomic nervous system across diverse patient populations, with older adults exhibiting heightened vulnerability due to age-related pharmacokinetic changes and polypharmacy
- nih.gov
Clinically, the toxidrome is defined by peripheral signs of parasympathetic blockade—including tachycardia, mydriasis, anhidrosis, hyperthermia, dry mucous membranes, urinary retention, and decreased bowel sounds—accompanied by central manifestations such as confusion, agitation, visual hallucinations, delirium, and potentially seizures or coma
- nih.gov
Clinically, the toxidrome is defined by peripheral signs of parasympathetic blockade—including tachycardia, mydriasis, anhidrosis, hyperthermia, dry mucous membranes, urinary retention, and decreased bowel sounds—accompanied by central manifestations such as confusion, agitation, visual hallucinations, delirium, and potentially seizures or coma
- nih.gov
Clinically, the toxidrome is defined by peripheral signs of parasympathetic blockade—including tachycardia, mydriasis, anhidrosis, hyperthermia, dry mucous membranes, urinary retention, and decreased bowel sounds—accompanied by central manifestations such as confusion, agitation, visual hallucinations, delirium, and potentially seizures or coma
Personalize your experience
Follow Anticholinergic toxicity and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.